Get started
Author

Marjo Hahka‐Kemppinen

BRAF mutations in metastatic melanoma: a possible association with clinical outcome.
2003 · Rajiv Kumar, Sabrina Angelini, et al. · PubMed · 206
A prognostic model and staging for metastatic uveal melanoma
2003 · Sebastian Eskelin, Seppo Pyrhönen, et al. · Cancer · 166
High expression levels of collagenase‐1 and stromelysin‐1 correlate with shorter disease‐free survival in human metastatic melanoma
2001 · Johanna Nikkola, Pia Vihinen, et al. · International Journal of Cancer · 136
Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma
2003 · T Kivelä, S Suciu, et al. · European Journal of Cancer · 131
Randomized, Double-Blind, Phase III Trial of Enzastaurin Versus Placebo in Patients Achieving Remission After First-Line Therapy for High-Risk Diffuse Large B-Cell Lymphoma
2016 · Michael Crump, Sirpa Leppä, et al. · Journal of Clinical Oncology · 125
A promising interferon plus four-drug chemotherapy regimen for metastatic melanoma.
1992 · S Pyrhönen, M Hahka-Kemppinen, et al. · Journal of Clinical Oncology · 109
Analysis of G1/S checkpoint regulators in metastatic melanoma
2000 · Ilari Sauroja, Johanna Smeds, et al. · Genes Chromosomes and Cancer · 85
Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD), and human leukocyte interferon for metastatic uveal melanoma
2002 · Seppo Pyrhönen, Marjo Hahka‐Kemppinen, et al. · Cancer · 77
PDF
Integrin chains ??1 and ??v as prognostic factors in human metastatic melanoma
2004 · Johanna Nikkola, Pia Vihinen, et al. · Melanoma Research · 76
Prognostic value of tumour vascularity in metastatic melanoma and association of blood vessel density with vascular endothelial growth factor expression
1999 · T. Vlaykova, P. Laurila, et al. · Melanoma Research · 71
Serum adhesion molecules and interleukin-2 receptor as markers of tumour load and prognosis in advanced cutaneous melanoma
2001 · M.-S. Vuoristo, S. Laine, et al. · European Journal of Cancer · 44
Immunohistochemically Detectable Bcl-2 Expression in Metastatic Melanoma: Association with Survival and Treatment Response
2002 · Tatyana Vlaykova, Lauri Talve, et al. · Oncology · 35
Randomized trial of dacarbazine versus bleomycin, vincristine, lomustine and dacarbazine (BOLD) chemotherapy combined with natural or recombinant interferon-?? in patients with advanced melanoma
2005 · Meri-Sisko Vuoristo, Marjo Hahka-Kemppinen, et al. · Melanoma Research · 33
The CD4+/CD8+ ratio as a prognostic factor in patients with metastatic melanoma receiving chemoimmunotherapy.
1996 · M Hernberg, T Muhonen, et al. · Journal of Clinical Oncology · 33
Vascularity and prognosis of metastatic melanoma
1997 · Tatyana Vlaykova, Timo Muhonen, et al. · International Journal of Cancer · 29
PDF
A randomized, open‐label clinical trial of tasisulam sodium versus paclitaxel as second‐line treatment in patients with metastatic melanoma
2014 · Omid Hamid, Robert Ilaria, et al. · Cancer · 28
PDF
High collagenase-1 expression correlates with a favourable chemoimmunotherapy response in human metastatic melanoma
2001 · J. Nikkola, P. Vihinen, et al. · Melanoma Research · 27
A placebo-controlled, randomized phase II study of maintenance enzastaurin following whole brain radiation therapy in the treatment of brain metastases from lung cancer
2012 · Bjørn H. Grønberg, Tudor Ciuleanu, et al. · Lung Cancer · 23
Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial
2009 · H. Joensuu, L. Sailas, et al. · Annals of Oncology · 22
PDF
Serum angiogenin levels predict treatment response in patients with stage IV melanoma
2007 · Pia Vihinen, Minna Kallioinen, et al. · Clinical & Experimental Metastasis · 21
Clinical Activity of Abemaciclib (LY2835219), a Cell Cycle Inhibitor Selective for CDK4 and CDK6, in Patients with Relapsed or Refractory Mantle Cell Lymphoma
2014 · Franck Morschhauser, Kamal Bouabdallah, et al. · Blood · 20
Prognostic value of β1 integrin expression in metastatic melanoma
2000 · P. Vihinen, J. Nikkola, et al. · Melanoma Research · 20
A Phase III Study Of Enzastaurin In Patients With High-Risk Diffuse Large B Cell Lymphoma Following Response To Primary Treatment: The Prelude Trial
2013 · Michael Crump, Sirpa Leppä, et al. · Blood · 18
The value of serum S-100β and interleukins as tumour markers in advanced melanoma
2000 · M.-S. Vuoristo, P. Kellokumpu-Lehtinen, et al. · Melanoma Research · 18
MIB-1 Immunoreactivity Correlates with Blood Vessel Density and Survival in Disseminated Malignant Melanoma
1999 · Tatyana Vlaykova, Lauri Talve, et al. · Oncology · 17
Works count: 49
Citation count: 1,656
H-index: 20
I10-index: 29
Year
Topic
Type